Biomarkers in acute lung injury--marking forward progress.
about
The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.The needle in the haystack: searching for biomarkers in acute respiratory distress syndrome.Pulmonary permeability assessed by fluorescent-labeled dextran instilled intranasally into mice with LPS-induced acute lung injury.Steroids for acute respiratory distress syndrome?Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patientsCurrent technology in the diagnosis of developmentally related lung disorders.Biomarkers of lung injury in critical care medicine: past, present, and future.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Mouse Models of Acute Respiratory Distress Syndrome: A Review of Analytical Approaches, Pathologic Features, and Common Measurements.Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients.Excessive mechanical stress increases HMGB1 expression in human lung microvascular endothelial cells via STAT3.Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.Radiation Mitigating Properties of Intranasally Administered KL4 Surfactant in a Murine Model of Radiation-Induced Lung Damage.Elevation of Serum PARK7 and IL-8 Levels Is Associated With Acute Lung Injury in Patients With Severe Sepsis/Septic Shock.Candidate Genes as Biomarkers in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome Based on mRNA Expression Profile by Next-Generation RNA-Seq Analysis.
P2860
Q33586556-69B33BD5-F214-4868-805B-0CDA4288CC97Q33750995-079ABCEC-1C54-4BBD-9634-2970E6846425Q33751893-6D3A961C-7C67-4A39-B895-81502E59BCAFQ33875318-E969E14A-EE77-4A60-8516-567511EE07D5Q34451061-D0778945-95AA-476C-A96C-43E1B2E993ECQ36917451-D685D000-D4D5-4067-B7A3-A9840078C058Q38039826-CCD64589-9463-4BF6-8CB6-97CBBA7A35E4Q38087680-BC58D59E-25D1-4A58-9170-949B6DB219DCQ38552059-5E0785E7-E921-4D51-9F93-97ED26CE51B6Q38571256-055F4B4C-739A-4079-B560-E75E27EBC2B7Q41650084-D4FE9969-24C9-4E29-8AF0-77BEDE3E0E26Q42117574-A3404636-D395-4215-A8EB-5244EBB46BDCQ44003095-7BA8689E-0CC0-471D-8D50-8AFFA48ED0BAQ47781707-18885035-F095-4635-BD56-A7D0F2622C1DQ53292003-1166A9B9-6E91-437A-A199-AE3421782712Q55270293-1C60A929-BED5-41EA-ADA7-F4503170791C
P2860
Biomarkers in acute lung injury--marking forward progress.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biomarkers in acute lung injury--marking forward progress.
@ast
Biomarkers in acute lung injury--marking forward progress.
@en
type
label
Biomarkers in acute lung injury--marking forward progress.
@ast
Biomarkers in acute lung injury--marking forward progress.
@en
prefLabel
Biomarkers in acute lung injury--marking forward progress.
@ast
Biomarkers in acute lung injury--marking forward progress.
@en
P2860
P1476
Biomarkers in acute lung injury--marking forward progress.
@en
P2093
Nicolas Barnett
P2860
P304
P356
10.1016/J.CCC.2011.04.001
P577
2011-07-01T00:00:00Z